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ABSTRACT The Na1-Ca21 exchanger is a plasma membrane protein expressed at high levels in cardiomyocytes. It extrudes
1 Ca21 for 3 Na1 ions entering the cell, regulating intracellular Ca21 levels and thereby contractility. Na1-Ca21 exchanger
activity is regulated by intracellular Ca21, which binds to a region (amino acids 371–508) within the large cytoplasmic loop
between transmembrane segments 5 and 6. Regulatory Ca21 activates the exchanger and removes Na1-dependent
inactivation. The physiological role of intracellular Ca21 regulation of the exchanger is not yet established. Yellow (YFP) and
cyan (CFP) ﬂuorescent proteins were linked to the NH2- and CO2H-termini of the exchanger Ca
21 binding domain (CBD) to
generate a construct (YFP-CBD-CFP) capable of responding to changes in intracellular Ca21 concentrations by FRET
efﬁciency measurements. The two ﬂuorophores linked to the CBD are sufﬁciently close to generate FRET. FRET efﬁciency was
reduced with increasing Ca21 concentrations. Titrations of Ca21 concentration versus FRET efﬁciency indicate a KD for Ca
21 of
;140 nM, which increased to ;400 nM in the presence of 1 mM Mg21. Expression of YFP-CBD-CFP in myocytes, generated
changes in FRET associated with contraction, suggesting that NCX is regulated by Ca21 on a beat-to-beat basis during
excitation-contraction coupling.
INTRODUCTION
Cytosolic Ca21 is a ubiquitous regulator that controls
cellular processes by setting the activity of many proteins.
Among these proteins is the Na1-Ca21 exchanger (NCX).
NCX is a plasma membrane protein particularly abundant in
myocardium that uses the energy of the transmembrane Na1
gradient to extrude Ca21 from the cell after each contraction
(Philipson and Nicoll, 2000). During each reaction cycle,
NCX transports three Na1 ions into the cell to extrude one
Ca21 ion. By pumping Ca21 out of the cell, the NCX protein
plays an important role in cardiac Ca21 homeostasis and
contractility.
Structural studies show that NCX has nine transmembrane
segments with a large intracellular loop located between
transmembrane segments 5 and 6 (Nicoll et al., 1999). This
large intracellular loop has multiple regulatory regions. In
particular, residues 371–508 form a regulatory Ca21 binding
site (Levitsky et al., 1994). Ca21 bound to this site is not
transported but activates exchange activity and removes
a Na1-dependent inactivation process (Hilgemann et al.,
1992b; Levitsky et al., 1994). The exact Ca21 concentration
dependence of the Ca21 regulatory effect is uncertain.
Electrophysiological approaches have determined appar-
ent afﬁnity values ranging from 22 nM (whole cell
measurements) to 400 nM (giant excised patches) (Hilge-
mann et al., 1992a). These conﬂicting results affect
interpretation of the physiological role of Ca21 regulation
in cardiac cells. The cytoplasmic Ca21 concentration in
a resting cardiac myocyte is ;100 nM. Thus, with an
apparent KD of 22 nM, the Ca
21 binding site of the
exchanger would be saturated at resting conditions, thereby
excluding the possibility of a dynamic tuning effect of Ca21
on the exchanger. In contrast, the lower apparent afﬁnity
constant of 400 nM would enable increases in cytoplasmic
Ca21 to up-regulate the exchanger during the excitation-
contraction coupling cycle.
To characterize the Ca21 dependency of regulation of the
exchanger, we isolated the Ca21 binding site of the
exchanger and determined Ca21 sensitivity both in vivo
and in vitro. To this end, we placed amino acid residues 371–
508 (Ca21 binding domain, CBD) between two ﬂuorescent
proteins (the yellow YFP and cyan CFP variants of green
ﬂuorescent protein) to produce the protein YFP-CBD-CFP.
Upon excitation, YFP and CFP act in a concerted manner to
give ﬂuorescent resonance energy transfer or FRET. FRET is
the nonradiative transfer of energy from a ﬂuorescent donor
to another excitable moiety; FRET is well established as
a technique to determine protein-protein interactions and
intramolecular conformational changes (Stryer, 1978). The
efﬁciency of this reaction is strongly dependent on the
distance between the two ﬂuorophores: a small variation in
distance can cause large changes in FRET efﬁciency (Stryer,
1978).
Since the exchanger Ca21 binding domain has been
shown to undergo major Ca21-induced conformational
changes (Levitsky et al., 1994), we predicted that upon
binding Ca21, YFP-CBD-CFP would alter conformation
causing a change in the distance or angle between the two
ﬂuorophores and therefore a change in FRET efﬁciency.
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We show that increasing intracellular Ca21 reduces FRET
efﬁciency suggesting a relaxation of the peptide. Finally, we
also demonstrate that YFP-CBD-CFP can sense changes in
intracellular Ca21 within physiological concentration ranges
found in actively contracting neonatal myocytes. These
results strongly support a physiological role of secondary
regulation of the exchanger by Ca21.
Our results suggest that it is possible to determine
a physiologically important function by examining a protein
‘‘module’’ in isolation from its parent: in this case, the core
Ca21 binding region of the Na1-Ca21 exchanger.
METHODS
Molecular biology
The CBD of NCX was placed between the donor moiety, cyan ﬂuorescent
protein, and the acceptor moiety, yellow ﬂuorescent protein. pEYFP C-1 and
pECFP N-1 (Clontech, Palo Alto, CA) were ligated together; an NheI/EcoRI
fragment (768 bp) from pEYFP C-1 was inserted into NheI/EcoR1 digested
pECFP N-1 to generate pYFP-CFP. The Ca21 binding domain of the
exchanger, amino acid residues 371–508, was ampliﬁed with two primers
such that the 5# primer incorporated an XhoI restriction site and ﬁve codons
encoding glycine residues before residue 371 (underlined) (AGATCTC-
GAGGCGGCGGCGGCGGCAGTAAGATCTT CTTTGAACAA) and the
3# primer incorporated ﬁve codons encoding glycine residues and an EcoR1
restriction site after residue 508 (underlined) (GCTGGCATCTTTACTTTT-
GAGGAGGGAGGAGGAGGAGGAATTCTGCA). The PCR product was
subcloned into pYFP-CFP using XhoI and EcoRI restriction enzymes. The
ﬁnal construct YFP-CBD-CFP was conﬁrmed by sequencing.
Cell culture
HEK293, Hela cells, and rat neonatal cardiac myocytes were grown in 35
mm glass bottom Petri dishes in standard culture medium. Rat neonatal
myocytes were prepared as described previously (Mitra and Morad, 1985);
24 h after isolation cardiac myocytes were deprived of serum. Petri dishes
were pretreated with either ﬁbronectin (Sigma Chemical, St. Louis, MO) or
Cell-Tak (Becton Dickinson Labware, Franklin Lakes, NJ). Transfection of
cDNAs was accomplished using GenePORTER (GFTinc., San Diego, CA).
FRET measurements
Data were acquired using a Nikon Eclipse TE300 microscope equipped with
a mercury lamp (Nikon, A-G Heinze, Lake Forrest, CA), a 403 oil
immersion lens (N.A. 1.2) and the following ﬁlter cubes (nm): 1. CFP cube
(CFPF): excitation (EX) 436 6 20, emission (EM) 480 6 40, dichroic 455
(longpass, DCLP); 2. YFP cube (YFPF): EX 500 6 20, EM 535 6 30,
DCLP 515; FRET cube (FRETF): EX 436 6 20, EM 535 6 30, DCLP 455
(Chroma Technologies, Rockingham, VT). Alternatively, LEDs (Light
Emitting Diodes, Lumileds; San Jose, CA) were used as light sources, two
emitting at 455 6 20 nm (royal blue) and one emitting at 505 6 15 nm
(cyan). The royal blue lights were placed in front of the CFP and FRET ﬁlter,
whereas the cyan light was located in front of the YFP ﬁlter; LEDs were
controlled by the camera driven shutter. This setup eliminated the
ﬂuctuations typically associated with a mercury lamp. Experiments were
performed at room temperature.
Steady-state FRET
Sequential images were captured with a SPOTII digital camera (Diagnostic,
Sterling Heights, MI). Control experiments conﬁrm that correction factors
values for donor (RD) and acceptor (RA) (measured as described in the
results) were independent of level of expression. RA and RD were found to be
0.54 6 0.01 (n ¼ 12) and 0.73 6 0.01 (n ¼ 15), respectively. These
correction factors were utilized to determine the true FRET signal indicated
as FRETC and measured as follows: FRETC ¼ FRETF  RD 3 CFPF 
RA 3 YFPF, where FRETF, CFPF, and YFPF indicate the type of ﬁlter
with which the light was acquired from a cell expressing both ﬂuorophores.
Cells were illuminated using the mercury lamp. Images were analyzed with
the National Institutes of Health Scion Image Program and background
was subtracted before FRET calculations. Before the experiment, external
medium was replaced with PBS.
FRET efﬁciency was quantiﬁed using the acceptor photobleaching
approach (Stryer, 1978; Llopis et al., 2000). For these measurements, wide-
ﬁeld illumination was obtained using the LED lights. YFP photobleaching
was completed after ;15 min of constant illumination (YFPF). CFP
emission images were acquired before and after YFP photobleaching using
the CFPF. Images were analyzed by quantifying the amount of ﬂuorescence
inside the cell. These values were used to determined FRET efﬁciency (E),
calculated as follow: E ¼ 1ICFPb/ICFPa, where I is the intensity of CFP
emission before (CFPb) and after (CFPa) YFP photobleaching.
Control cells were maintained in the presence of PBS, whereas cells in
0 Ca21 were incubated in 160 mM MOPS, 1 mM EGTA, 5 mM ionomycin
pH 7.4 (adjusted with KOH) for ;10 min prior experiment.
Real time FRET
Measurements were performed using the MultiSpec Micro-Imager system
from Optical Insight (Santa Fe, NM) that allows monitoring of CFP and YFP
ﬂuorescence emissions simultaneously. The ratio between YFP and CFP
emission is then calculated as an indicator of FRET efﬁciency. The
MultiSpec Micro-Imager is directly attached to the microscope and is
equipped with a 505 nm long-pass dichroic ﬁlter used to separate the CFP
signal from the YFP signal, a CFP emission ﬁlter (4806 30 nm) and an YFP
emission ﬁlter (535 6 40 nm). The excitation ﬁlter was 436 6 20 nm.
Images were captured with a fast high-resolution digital camera (Cool-
SNAP-fx 12bit Cooled Monochrome Digital Camera, Roper Scientiﬁc,
Tucson, AZ) and acquired in a PC using the MetaFluor6.1 Fluorescence
ratio imaging system (Universal Imaging Corporation, Downingtown, PA).
For all experiments only cells with nonsaturating levels of ﬂuorescence are
used. Cells were maintained in Tyrode’s solution supplemented with 1.8
mM CaCl2 (pH ¼ 7.4).
In vitro FRET measurements
HEK293 cells were cultured in 100 3 20 mm regular culture dishes and
transfected with 5 mg DNA. Two to 3 days after transfection, cells were
rinsed once with a solution containing 160 mM MOPS, 1 mM EGTA,
adjusted to pH 7.2 with KOH and then solubilized using 0.5% Triton X-100,
dissolved in 2 ml of the same buffer. After centrifugation, the supernatant
was collected and placed in a quartz cuvette mounted in a spectroﬂuorometer
(Photon Technology International, Model C-44/2000, Lawrenceville, NJ).
CFP and YFP emission spectra were obtained by exciting at 434 nm and
measuring emission between 460–600 nm. Both excitation and emission
slits were set at 4 nm.
For ratio measurements, samples were excited at 434 nm and emission
was measured at 472 and 524 nm. CaCl2 was added directly to the cuvette
equipped with a magnetic stir bar. After addition of Ca21, a shift of 0.01–
0.02 pH units was measured at the end of the experiment. Control
experiments using cytoplasmic CFP and YFP show that this change in pH
did not affect the spectra of the ﬂuorophores and did not signiﬁcantly alter
the afﬁnity of EGTA for Ca21, since the replacement of EGTA with 1 mM
BAPTA, a less pH sensitive calcium buffer, did not modify the results (not
shown).
Free [Ca21] was calculated using the MAXC program.
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RESULTS
Previous studies have demonstrated that the Na1-Ca21
exchanger has a Ca21 regulatory binding site, which
activates the exchanger (DiPolo, 1979; Hilgemann, 1992a).
Biochemical evidence localized this regulatory site to lie
within the large cytoplasmic loop of the exchanger,
speciﬁcally between residues 371 and 508 (Levitsky et al.,
1994). This region was shown to undergo substantial change
in conformation upon the binding of Ca21, as indicated by
a shift in electrophoretic mobility during SDS-PAGE in the
presence or absence of Ca21 (Levitsky et al., 1994). These
results provided the rational for creating a system to
noninvasively monitor these movements in vivo and to
determine the range of Ca21 concentrations required to pro-
duce conformational changes. To achieve this goal, we con-
structed a peptide consisting of the CBD of the exchanger
(amino acid residues 371–508) with the NH2- and CO2H-
termini linked to YFP and CFP (YFP-CBD-CFP) (Fig. 1 A),
respectively. This construct is analogous to a well charac-
terized Ca21-indicator protein consisting of CFP-calmodu-
lin-calmodulin binding peptide-YFP, known as Cameleon
(Miyawaki et al., 1997). Binding of Ca21 to the Cameleon
produces an increase in FRET efﬁciency indicating a shift in
the protein to a more compact state in the presence of Ca21.
Detection of FRET from YFP-CBD-CFP
To determine if the ﬂuorophores linked to the CBD were
sufﬁciently close to generate FRET,we expressedYFP-CBD-
CFP inmammalian cells and assessed FRETby using both the
three cubes method and the acceptor photobleaching
technique (Stryer, 1978; Sorkin et al., 2000; Erickson et al.,
2001). Fig. 1 B shows HEK293 cells expressing YFP-CBD-
CFP and the corresponding corrected FRET (FRETC)
examined with the three cubes method. Brieﬂy, FRETC was
obtained by using three ﬁlters indicated as CFP, YFP, and
FRET. The CFP and YFP ﬁlters allow excitation and
detection of light from the CFP and YFP ﬂuorophores,
respectively. The FRET ﬁlter is a hybrid ﬁlter, which permits
excitation of the donor (CFP) and detection of light from the
acceptor (YFP). Ideally, any signal detected through the
FRET ﬁlter would originate from transfer of energy fromCFP
to YFP and therefore represent FRET. However, the emission
spectra of CFP and YFP partially overlap, and the emitted
light measured through the FRET ﬁlter is contaminated by the
ﬂuorescence due to the direct excitation of both ﬂuorophores.
To dissect these components (Sorkin et al., 2000; Erickson
et al., 2001) CFP and YFP were expressed separately and for
each ﬂuorophore, we divided the emission from the FRET
ﬁlter by the emission measured with either the CFP (for CFP)
or YFP (for YFP) ﬁlters. This correction factor (R) is
independent of the amount of ﬂuorescent protein and was
utilized to determine the true FRET signal (FRETC; see
Methods). As is shown in Fig. 1 B, we successfully detected
FRET generated by both YFP-CBD-CFP and Cameleon. To
corroborate our ﬁndings, we coexpressed cytoplasmic CFP
and YFP in the same cells and, as expected, no FRET was
detected.
FIGURE 1 FRET determination using the
three cubes and the acceptor photobleaching
techniques. (A) Schematic representation of the
Na1-Ca21 exchanger topology and the YFP-
CBD-CFP construct. (B) An example of
assessment of FRET using the three cubes
method for the following cytoplasmic con-
structs: cameleon, a well-characterized con-
struct generating Ca21-dependent FRET
(Miyawaki et al., 1997); CFP and YFP coex-
pressed; and the exchanger Ca21 binding
domain linked to YFP and CFP (YFP-CBD-
CFP). The images were acquired with the CFP,
YFP, and FRET ﬁlters and FRETC was
calculated as described in the text. Notice the
lack of FRET in cells expressing cytoplasmic
CFP and YFP. (C) Example of increase in the
CFP emission after YFP photobleaching in
a cell expressing YFP-CBD-CFP. CFP images
were acquired immediately before and after
YFP photobleaching. After YFP photobleach-
ing, achieved with maximal excitation at 500
nm for 800 s, CFP emission increased by 22%,
demonstrating the presence of FRET. (D)
FRET efﬁciency was determined using the
increase in CFP emission (see Methods). Cells
incubated with 5 mM ionomycin in the
presence of 1 mM EGTA (0 Ca21) show an increase in FRET efﬁciency, as compared to untreated cells (Ca21 ;100 nM). FRET efﬁciency values are
0.27 6 0.03 (n ¼ 7) and 0.16 6 0.05 (n ¼ 3) (p , 0.05), respectively. The result indicates that low Ca21 favors FRET.
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FRET was also determined by acceptor photo bleaching
(YFP). This method relies on the concept that when FRET
occurs part of the energy of excited CFP is transferred to
YFP resulting in decreased in CFP emission (Stryer, 1978).
This energy transfer is eliminated by bleaching of YFP and
leads to an increase in CFP emission. Fig. 1 C illustrates the
time course of YFP photobleaching, obtained with a constant
illumination of the cells at 500 6 20 nm for ;15 min, and
the corresponding increase in CFP emission of YFP-CBD-
CFP expressed in HEK293 cells. CFP and YFP values were
normalized to their own maximum. After complete YFP
bleaching, the CFP emission increased by 22%, indicative of
FRET occurring between the two ﬂuorophores. Photo-
bleaching of YFP in cells coexpressing cytoplasmic CFP
and YFP did not modify CFP emission (not shown).
The increase in CFP emission was used to determine the
efﬁciency with which energy was transferred from CFP to
YFP (FRET efﬁciency; see Methods), which is dependent on
ﬂuorophore proximity (Stryer, 1978). The average value of
FRET efﬁciency obtained from cells expressing YFP-CBD-
CFP and incubated in PBS was lower than that in cells treated
with 5 mM ionomycin in the presence of 1 mM EGTA to
chelate cytoplasmic Ca21 (see lower panel, Fig. 1 D). The
result indicates that cytoplasmic Ca21 drives the exchanger
Ca21 binding domain into a conformation that decreases
FRET.
The Ca21 binding region of the exchanger senses
physiological Ca21 concentrations
Since the three cubes and the acceptor photobleaching
methods are only useful to determine FRET under steady-
state conditions, we utilized a ratiometric approach tomonitor
changes in FRET during interventions. When FRET occurs,
excitation of CFP causes YFP emission at the expense of CFP
emission.Hence, theYFP/CFPﬂuorescence ratio is ameasure
of FRET efﬁciency. Fig. 2 shows how the CFP and YFP
emission and the corresponding YFP/CFP ratio value
changed upon addition of 10 mM carbachol to the external
solution of HeLa cells expressing YFP-CBD-CFP and the
muscarinic receptor M1. Activation of M1 by carbachol
creates a transient increase in cytoplasmic Ca21 (Felder,
1995), which led to a decrease in FRET. As shown in the right
panel of Fig. 2, HeLa cells coexpressing cytoplasmic CFP,
YFP, and M1 receptor do not show any change in the FRET
ratio value, corroborating the speciﬁcity of the effect.
To determine the range of Ca21 concentrations to which
YFP-CBD-CFP responded, the construct was expressed in
HEK293 cells and then used for in vitro studies. After
detergent lysis of the cells in an EGTA-buffered, low Ca21
solution, the FRET ratio of YFP-CBD-CFP was monitored in
a spectroﬂuorimeter after additions of Ca21. Fig. 3 A shows
the emission spectra of solubilized YFP-CDB-CFP before
and after addition of 1 mMCa21. Ca21 induced a decrease in
the FRET ratio value. The changes in FRET were plotted
versus free Ca21 concentration and the values were ﬁt to the
Hill function to determine the apparent dissociation constant
(KD). As shown in Fig. 3 B, the ﬁt of the averages from 8
different experiments gave a KD for Ca
21 of 140 nM and
a Hill coefﬁcient of 2.9. SinceMg21 competes for Ca21 at the
regulatory site (Levitsky et al., 1994; Wei et al., 2002), we
also measured the KD for Ca
21 in the presence of 1 mM
Mg21 (n ¼ 4). The apparent Ca21 afﬁnity for FRET was
shifted to 383 nM. However, Mg21 by itself did not evoke
any changes in FRET up to a concentration of 3 mM (not
shown), perhaps suggesting that Mg21 can interact with the
Ca21-binding site of the exchanger but is incapable of
generating a detectable conformation change.
GFP molecules can potentially form dimers (Tsien, 1998),
and we investigated the possibility of intermolecular FRET
FIGURE 2 Ca21 decreases FRET: effect of changes
in intracellular Ca21 on CFP (open circles) and YFP
(shaded circles) emissions (top) and corresponding
YFP/CFP ratio (bottom), from HeLa cells expressing
YFP-CBD-CFP (right) or CFP 1 YFP (left) in the
presence of the muscarinic receptor M1. Cytoplasmic
Ca21 was increased by activation of the muscarinic
receptor M1 with the agonist carbachol. The YFP/CFP
ratio of cells expressing YFP-CBD-CFP signiﬁcantly
decreased with the induced rise in intracellular Ca21
concentration, whereas the ratio from cells expressing
cytoplasmic CFP and YFP remained constant. Arrows
indicate the addition of 10 mM carbachol to the
external Tyrode’s solution.
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induced by the dimerization of YFP-CBD-CFP. The efﬁ-
ciency of dimerization of adjacent molecules is dependent on
protein concentration. Fig. 3 C shows that this is not the case,
since the ratio between YFP/CFP was not affected by a
eightfold dilution of YFP-CBD-CFP. The result indicates that
FRET occurs exclusively between CFP and YFP of the same
molecule and measures the intrinsic movements of the con-
nectingmoiety; i.e., it gives an indication of themovements of
the Ca21 binding domain of the Na1-Ca21 exchanger.
FRET is altered by mutations known to reduce
the Ca21 afﬁnity of the exchanger
Previous studies have shown that point mutations (D447V
and D498I) within the Ca21 binding domain of the
exchanger decreased Ca21 afﬁnity (Matsuoka et al., 1995).
Using FRET, we measured the Ca21 dependency of YFP-
CBD-CFP with either D447 or D498 mutated. As shown in
Fig. 4 A, mutation of the aspartate at position 447 to valine
shifted the Ca21 afﬁnity. The response to Ca21 was best ﬁt
with a linear combination of two Hill functions with apparent
Ca21 afﬁnities of 1.2 and 2.5 mM and relative contributions
of 76% and 24%, respectively. The mutation also decreased
the total change in FRET (DFRET) by 13% compared to WT
(Fig. 4 B). Replacement of aspartate 498 with an isoleucine
also exposed two Ca21 binding sites with apparent afﬁnities
of 1.2 and 130 mM (relative contributions were 59% and
41%, respectively (Fig. 4 A) and reduced the total change in
FRET by 29% (Fig. 4 B).
These data suggest that mutation of these residues not only
decreases Ca21 afﬁnity but also partially hinders the
rearrangement of the protein after the binding of Ca21.
The double mutant D447V-D498I showed a Ca21 insen-
sitive YFP/CFP ratio, although a full-length exchanger with
this double mutation retains weak Ca21 regulation (Levitsky
et al., 1994; Matsuoka et al., 1995).
The exchanger Ca21 binding domain undergoes
conformational changes during
excitation-contraction coupling
One objective of our study was to determine if the Ca21
binding site of the Na1-Ca21 exchanger could sense changes
in cytoplasmic Ca21 during each contraction cycle. To
address this question, we expressed YFP-CBD-CFP in rat
neonatal cardiac myocytes and monitored changes in FRET
during spontaneous contractions. Three to four days after
DNA transfection, media was replaced with regular Tyrodes
solution and the spontaneous contractions of myocytes
expressing YFP-CBD-CFP were monitored at room temper-
ature. Fast acquisition of simultaneous images of CFP and
YFP revealed a change in the YFP/CFP ﬂuorescence ratio,
which correlated with myocyte contraction. Consistent with
our previous observations, the YFP/CFP ﬂuorescence ratio
was maximal during relaxation and decreased signiﬁcantly
FIGURE 3 Fluorescence properties of YFP-CBD-
CFP in vitro. (A) Emission spectra of solubilized
YFP-CBD-CFP (excited at 434 nm) in the absence or
presence of 1 mM free Ca21. Ca21 addition induced
a decrease in the YFP/CFP ratio without altering the
spectral properties of YFP-CBD-CFP. (B) Changes
in the emission ratio versus Ca21 concentration.
Each point represents the average of eight experi-
ments. Emission ratios were normalized to the value
obtained in the absence of Ca21 and ﬁt to the Hill
function (1/1 1 ([Ca21]/KD)
n), where KD is the
dissociation constant and n the Hill coefﬁcient. The Ca21 titration curve has a KD of 140 nM and a Hill coefﬁcient of 2.9. Addition of 1 mMMg
21 (n) induced
a shift in the KD value to 383 nM. (C) Emission spectra of YFP-CBD-YFP (excited at 434 nm) before and after an eightfold dilution. Both spectra were
normalized to emission at 514 nm.
FIGURE 4 Mutation of aspartates 447 and 498 alters
Ca21 dependency of FRET signals. (A) Changes in
FRET value versus free Ca21 concentrations for WT
and mutants D447V and D498I. Emission ratios were
normalized to the value obtained in the absence of
Ca21 and ﬁtted to a single Hill function for wild-type
and to the sum of two Hill functions for mutants
D447V and D498I. KD values are WT, 140 nM;
D447V, 1.2 and 2.5 mM; and D498I, 1.2 and 130 mM.
Each point is the mean of eight experiments for WT,
ﬁve experiments for D497V, and six experiments for
D498I. (B) The graph shows the total change in FRET
signal (DFRET) for the WT and mutants D447V and D498I. Values are WT¼ 0.1096 0.005 (n¼ 8), D447V¼ 0.0916 0.003 (n¼ 5), and D498I¼ 0.0756
0.005 (n ¼ 5). DF is the difference between the YFP/CFP value in 0 Ca21 and YFP/CFP value in presence of high [Ca21].
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during contractions when cytoplasmic Ca21 was elevated
(Fig. 5). Prolonged decreases in FRET correlated with
protracted states of contractions (Fig. 5 A). Another example
of a contracting cardiac myocyte is shown in Fig. 5 B. In this
case the myocyte displayed fast twitches, which were
associated with rapid changes in the FRET signal. The
corresponding changes in both CFP and YFP emission are
also shown for this myocyte and, as expected, opposite
changes in YFP and CFP emission were associated with
FRET oscillations. Similar results were observed in an
additional 22 myocytes. The data indicate that the regulatory
Ca21 binding site of the exchanger responds to changes in
Ca21 that occur during excitation-contraction coupling.
Control experiments monitoring the ﬂuorescence of myo-
cytes expressing cytoplasmic CFP and YFP or mutants
D498I and D447V demonstrated no changes in FRET with
contraction (data not shown).
DISCUSSION
The regulatory CBD of the Na1-Ca21 exchanger consists of
amino acid residues 371 to 508 (Levitsky et al., 1994). The
afﬁnity of the CBD for Ca21 has been extensively studied
using techniques such as 45Ca21 overlay, radioisotopic ﬂux,
and electrophysiology. These techniques have characterized
the general properties of Ca21-induced regulation of the
Na1-Ca21 exchanger. Nevertheless, Ca21 regulation is dif-
ﬁcult to study in intact myocytes, and an accurate in vivo
value for Ca21 afﬁnity has proven to be elusive with values
ranging from 20–400 nM (Miura and Kimura, 1989;
Hilgemann et al., 1992a; Reeves and Condrescu, 2003).
Problems have included experimental limitations such as
difﬁculties in controlling intracellular Ca21 and measuring
exchanger activity, lack of speciﬁc inhibitors of Na1-Ca21
exchange, and partial overlap of the afﬁnity curves for
transported and regulatory Ca21. In our study, this issue was
addressed using a noninvasive optical approach to determine
the range of cytoplasmic Ca21 needed to activate the Na1-
Ca21 exchanger in living cells. By linking YFP and CFP
ﬂuorophores to the NH2- and CO2H-termini of the CBD of
the exchanger, conformational changes of the protein were
translated into changes in FRET, enabling the selective study
of CBD in vitro and in vivo in contracting myocytes.
First, we determined the presence of FRET between the
two ﬂuorophores linked to the CBD by using two well
established independent techniques: the three cubes method
(Sorkin et al., 2000; Erickson et al., 2001) and acceptor
photobleaching (Llopis et al., 2000). Both techniques
demonstrated that YFP-CBD-CFP expressed in mammalian
cells generates FRET. To determine if FRET changed with
Ca21, we coexpressed YFP-CBD-CFP with the muscarinic
receptor M1. Activation of M1 leads to release of Ca21 from
internal stores. Addition of carbachol, a M1 agonist, caused
a rapid decrease in FRET; this reduction was transient, as
Ca21 is resequestered into the endoplasmic reticulum. These
data indicate that the Ca21 binding site of the Na1-Ca21
exchanger can sense variations in cytoplasmic Ca21 and that
binding of Ca21 induces a change in the conformation of
FIGURE 5 The Ca21 binding site of the
exchanger can sense changes in Ca21
during excitation-contraction coupling. (A)
An example of rat neonatal cardiomyocytes
expressing YFP-CBD-CFP and the corre-
sponding changes in YFP/CFP ratio during
spontaneous activity of the myocytes.
Arrows indicate the time when the images
were acquired. Myocytes were kept in
Tyrode’s solution at room temperature
and ﬂuorescence was monitored each
second. The vertical bar indicates the
YFP/CFP ratio value in pseudocolor. The
decrease in the ratio of YFP/CFP correlates
with myocyte contraction (not shown). (B)
Another example of changes in YFP/CFP
ratio during spontaneous contractions of a
different neonatal cardiac myocyte. In this
case, the contractions were faster. The
lower panel shows how the CFP and YFP
emissions changed during time. Changes in
YFP/CFP values were due to simultaneous
and opposite oscillations in CFP and YFP
emissions. Images were acquired every
second.
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the CBD. The Ca21-dependent decrease in FRET could
potentially be due to a conformational change of the CBD
moving the CFP and YFP further apart or changing the
orientation of the two ﬂuorophores with respect to one
another. A combination of these two mechanisms may also
be occurring. Our results cannot discriminate between these
possibilities. However, we favor the ﬁrst interpretation since
both CFP and YFP were linked to the Ca21 binding domain
by a series of glycines that likely confers ﬂexibility to the
orientation of the ﬂuorophores. Interestingly, YFP-CBD-
CFP shows a reduction in FRET upon Ca21 binding,
a behavior opposite to that observed with Cameleon,
a ﬂuorescent Ca21 indicator that increases FRET efﬁciency
upon binding Ca21.
To determine the sensitivity of the regulatory Ca21
binding site for Ca21, we performed in vitro measurements.
The FRET efﬁciency of expressed YFP-CBD-CFP from
solubilized cells was assessed as a function of Ca21
concentration. The Ca21 needed to cause a 50% reduction
in FRET was ;140 nM in the absence of Mg21 and ;400
nM in the presence of 1 mM Mg21. The rightward shift of
the FRET Ca21 afﬁnity in the presence of Mg21 corrobo-
rates previous studies (Levitsky et al., 1994; Wei et al., 2002)
showing competition between the two ions for the Ca21
regulatory site.
In sum, these results imply that a majority of Na1-Ca21
exchangers are in an inactivated state at resting Ca21
concentrations (;100 nM) and that small increases in
cytoplasmic Ca21 content could have a large effect on Na1-
Ca21 exchanger activity, assuming that the Ca21 afﬁnity of
the CBD reﬂects that of the intact exchanger. Activation of
the exchanger would be maximal by ;1 mM internal Ca21.
Two clusters of aspartate residues located within the
exchanger Ca21 binding domain have previously been
shown to be important for binding. Point mutations at either
of these sites alter Ca21 afﬁnity as measured biochemically
by 45Ca21 overlay (Levitsky et al., 1994) and functionally by
the giant excised patch technique (Matsuoka et al., 1995).
Mutation of residues D447 or D498 lowered the apparent
afﬁnity for Ca21 from 0.4 to 1.8 and 1.4 mM, respectively
(Matsuoka et al., 1995). These same mutations also cause
a rightward shift of the Ca21 dependency when studied with
the 45Ca21 overlay technique (Levitsky et al., 1994). We
investigated the changes in FRET associated with Ca21
binding for the mutants D447V, D498I, and the double
mutant D447V/D498I. Our data show that replacement of
aspartate 447 with a valine altered the Ca21 binding curve
and revealed the presence of low and high afﬁnity sites with
KD values of 1.2 and 2.4 mM, respectively. The biphasic
form of the Ca21 titration was more accentuated by the
replacement of aspartate 498 with valine since this mutation
produced a drastic rightward shift of the low afﬁnity site
(KD.100mM). The presence of a biphasic response of FRET
to Ca21 could represent the equilibrium of the protein
between multiple states with different FRET efﬁciencies. In
addition to alter Ca21 afﬁnity, signiﬁcant reductions (10–
30%) in DFRET was also observed with both mutants.
Finally, a complete lack of change in FRET was observed
when the two mutations were combined. The ﬁndings
corroborate the importance of these residues in Ca21 reg-
ulation of the exchanger.
To determine if activation of the Na1-Ca21 exchanger
by the binding of regulatory Ca21 could occur during
excitation-contraction coupling, we expressed YFP-CBD-
CFP in neonatal cardiac myocytes and measured the change
in FRET upon contraction. Our data clearly show oscil-
lations in the YFP/CFP ﬂuorescence ratio associated with
myocyte contraction. FRET was maximal during relaxation
and decreased during contraction. The changes in ﬂuores-
cence were fast enough to track each contraction of the
myocyte. The changes in FRET were not motion artifacts, as
FRET changes were not detected when mutants with reduced
Ca21 afﬁnity (D447V and D498I) were expressed in the
myocytes.
In summary, the results demonstrate that the Ca21
regulatory site of the Na1-Ca21 exchanger can sense
changes in Ca21 within the physiological range and that
the rearrangement of the protein upon the binding of Ca21 is
fast enough to follow the rapid variations in cytoplasmic
Ca21 that occur during excitation-contraction coupling. The
same Ca21-induced conformational changes that cause
changes in FRET presumably also lead to activation of ex-
change activity. A caveat to our conclusions results from the
fact that the data were obtained using a soluble form of the
CBD that may not have identical characteristics to the Ca21
binding site on the full length, intact exchanger protein. Also,
Ca21 levels in the subsarcolemmal environment where the
CBD would normally be located may be different from those
in the bulk cytoplasm. Further work to investigate these
issues is underway.
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